4.8 Article

Regulation of Cellular Heterogeneity and Rates of Symmetric and Asymmetric Divisions in Triple-Negative Breast Cancer

Journal

CELL REPORTS
Volume 24, Issue 12, Pages 3237-3250

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2018.08.053

Keywords

-

Categories

Funding

  1. Israel Cancer Research Fund
  2. Israel Science Foundation [2309/15, 2511/17]
  3. United States-Israel Binational Science Foundation [2015205]
  4. Israel Cancer Association
  5. Jacob and Lena Joels Memorial Foundation
  6. Lower Saxony-Israel Research Cooperation Program
  7. Janey Scholarship
  8. Leonard and Faigel Shapiro Fellowship
  9. Bester Scholarship Fund
  10. Brody Foundation Fellowship
  11. Albert Sweet Scholarship
  12. Division Of Research On Learning
  13. Directorate for STEM Education [2015205] Funding Source: National Science Foundation

Ask authors/readers for more resources

Differentiation events contribute to phenotypic cellular heterogeneity within tumors and influence disease progression and response to therapy. Here, we dissect mechanisms controlling intratumoral heterogeneity within triple-negative basal-like breast cancers. Tumor cells expressing the cytokeratin K14 possess a differentiation state that is associated with that of normal luminal progenitors, and K14-negative cells are in a state closer to that of mature luminal cells. We show that cells can transition between these states through asymmetric divisions, which produce one K14(+) and one K14(-) daughter cell, and that these asymmetric divisions contribute to the generation of cellular heterogeneity. We identified several regulators that control the proportion of K14(+) cells in the population. EZH2 and Notch increase the numbers of K14(+) cells and their rates of symmetric divisions, and FOXA1 has an opposing effect. Our findings demonstrate that asymmetric divisions generate differentiation transitions and heterogeneity, and identify pathways that control breast cancer cellular composition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Pathway-based network modeling finds hidden genes in shRNA screen for regulators of acute lymphoblastic leukemia

Jennifer L. Wilson, Simona Dalin, Sara Gosline, Michael Hemann, Ernest Fraenkel, Douglas A. Lauffenburger

INTEGRATIVE BIOLOGY (2016)

Article Biochemistry & Molecular Biology

p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion

Aharon Helman, Agnes Klochendler, Narmen Azazmeh, Yael Gabai, Elad Horwitz, Shira Anzi, Avital Swisa, Reba Condiotti, Roy Z. Granit, Yuval Nevo, Yaakov Fixler, Dorin Shreibman, Amit Zamir, Sharona Tornovsky-Babeay, Chunhua Dai, Benjamin Glaser, Alvin C. Powers-, A. M. James Shapiro, Mark A. Magnuson, Yuval Dor, Ittai Ben-Porath

NATURE MEDICINE (2016)

Article Multidisciplinary Sciences

Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations

Daphne Sun, Simona Dalin, Michael T. Hemann, Douglas A. Lauffenburger, Boyang Zhao

SCIENTIFIC REPORTS (2016)

Article Multidisciplinary Sciences

Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements

Leila Pirhaji, Pamela Milani, Simona Dalin, Brook T. Wassie, Denise E. Dunn, Robert J. Fenster, Julian Avila-Pacheco, Paul Greengard, Clary B. Clish, Myriam Heiman, Donald C. Lo, Ernest Fraenkel

NATURE COMMUNICATIONS (2017)

Article Oncology

Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapy

Albert Grinshpun, Nancy Gavert, Roy Zvi Granit, Hadas Masuri, Ittai Ben-Porath, Shani Breuer, Aviad Zick, Shai Rosenberg, Myriam Maoz, Avital Granit, Eli Pikarsky, Ravid Straussman, Tamar Peretz, Amir Sonnenblick

CANCER BIOLOGY & THERAPY (2018)

Article Biochemistry & Molecular Biology

Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers

Albert Grinshpun, Naama Halpern, Roy Zvi Granit, Ayala Hubert, Tamar Hamburger, Yael Laitman, Einat Shacham-Shmueli, Yehudit Peerless, Eitan Friedman, Tamar Peretz

EUROPEAN JOURNAL OF HUMAN GENETICS (2018)

Article Multidisciplinary Sciences

Extensive changes in DNA methylation are associated with expression of mutant huntingtin

Christopher W. Ng, Ferah Yildirim, Yoon Sing Yap, Simona Dalin, Bryan J. Matthews, Patricio J. Velez, Adam Labadorf, David E. Housman, Ernest Fraenkel

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Medicine, Research & Experimental

Axes of differentiation in breast cancer: untangling stemness, lineage identity, and the epithelial to mesenchymal transition

Roy Z. Granit, Michal Slyper, Ittai Ben-Porath

WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2014)

Article Multidisciplinary Sciences

Network Modeling Identifies Patient-specific Pathways in Glioblastoma

Nurcan Tuncbag, Pamela Milani, Jenny L. Pokorny, Hannah Johnson, Terence T. Sio, Simona Dalin, Dennis O. Iyekegbe, Forest M. White, Jann N. Sarkaria, Ernest Fraenkel

SCIENTIFIC REPORTS (2016)

Article Oncology

Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance

Simona Dalin, Mark R. Sullivan, Allison N. Lau, Beatrice Grauman-Boss, Helen S. Mueller, Emanuel Kreidl, Silvia Fenoglio, Alba Luengo, Jacqueline A. Lees, Matthew G. Vander Heiden, Douglas A. Lauffenburger, Michael T. Hemann

CANCER RESEARCH (2019)

Article Oncology

Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer

Noa Harpaz, Yair Eli Gatt, Roy Zvi Granit, Hila Fruchtman, Ayala Hubert, Albert Grinshpun

JOURNAL OF ONCOLOGY (2020)

Article Multidisciplinary Sciences

Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel

Helen S. Mueller, Colin E. Fowler, Simona Dalin, Enrico Moiso, Tee Udomlumleart, Salil Garg, Michael T. Hemann, Jacqueline A. Lees

Summary: Epigenetic regulators are crucial in cancer treatment, but resistance mechanisms to their inhibition are not well understood. A study on PRMT5 inhibitors in lung adenocarcinoma cell lines revealed a drug-induced transcriptional switch leading to rapid resistance. The resistant state, stabilized across LUAD variants, also showed vulnerabilities to other chemotherapeutics like paclitaxel, due to the presence of STMN2. This gene was found to be essential for both PRMT5 inhibition resistance and sensitivity to paclitaxel, highlighting a potential therapeutic combination for cancer treatment.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemistry & Molecular Biology

RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer

Ohad Tarcic, Roy Z. Granit, Ioannis S. Pateras, Hadas Masury, Bella Maly, Yaara Zwang, Yosef Yarden, Vassilis G. Gorgoulis, Eli Pikarsky, Ittai Ben-Porath, Moshe Oren

CELL DEATH AND DIFFERENTIATION (2017)

No Data Available